Professor of Medicine, University Pittsburgh
Rheumatology
Dr. Chester V. Oddis, MD
|
|
Give Review
Chester V. Oddis practices Rheumatology. He received 6 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Pittsburgh Magazine", "Fellow", "Fellow (FACR)" and "Top MD". Doctor Chester V. Oddis, MD is a published doctor. He has 99 publications published. The most current publication "Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis." He accepts Medicare.
Publications
- Immune-mediated statin myopathy.
- Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers.
- The pulmonary histopathology of anti-KS transfer RNA synthetase Syndrome.
- Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
- Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.
- Predictors of clinical improvement in rituximab-treated refractory adult and juvenile Dermatomyositis and adult polymyositis.
- The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase Syndrome.
- Connective tissue Disease related interstitial lung Diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...
- Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation.
- Association of severity of coexisting patellofemoral disease with increased impairments and functional limitations in patients with knee osteoArthritis.
- Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
- Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid Arthritis-associated interstitial lung disease.
- Idiopathic Pulmonary Fibrosis Patients With Antibodies to Heat Shock Protein 70 Have Poor Prognoses.
- Rituximab in the treatment of refractory adult and juvenile Dermatomyositis and adult polymyositis: A randomized, placebo-phase trial.
- Therapeutic advances in myositis.
- Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.
- Paraneoplastic myalgias and myositis.
- Therapeutic approaches in myositis.
- Agility and perturbation training techniques in exercise therapy for reducing pain and improving function in people with knee osteoArthritis: a randomized clinical trial.
- Interstitial lung Disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
- Pulmonary manifestations of the idiopathic inflammatory myopathies.
- The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase Syndrome.
- Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.
- Ultraviolet radiation intensity predicts the relative distribution of Dermatomyositis and anti-Mi-2 autoantibodies in women.
- Effect of baseline quadriceps activation on changes in quadriceps strength after exercise therapy in subjects with knee osteoArthritis.
- Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung Disease.
- Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.
- Anti-U3 RNP autoantibodies in Systemic sclerosis.
- Reliability and validity of the myositis Disease activity assessment tool.
- The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoArthritis: a report from the glucosamine/chondroitin Arthritis intervention trial.
- Severe hydroxychloroquine myopathy.
- Anti-Jo-1 antibody levels correlate with Disease activity in idiopathic inflammatory myopathy.
- HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis aut...
- Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European A...
- Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoArthritis.
- Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clini...
- Treatment of antisynthetase-associated interstitial lung Disease with tacrolimus.
- Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
- Effects of doxycycline on progression of osteoArthritis: results of a randomized, placebo-controlled, double-blind trial.
- Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic Dermatomyositis.
- Outcomes and Disease activity measures for assessing treatments in the idiopathic inflammatory myopathies.
- Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoArthritis drug.
- Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
- Idiopathic inflammatory myopathies: a treatment update.
- Critical requirement for professional APCs in eliciting T Cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis.
- Idiopathic inflammatory myopathy: management and prognosis.
- Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/Dermatomyositis.
- Myositis-Specific and -Associated Autoantibodies: A Review From the Clinical Perspective.
- International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indic...
- Abdominal computed tomography scan in acute Lupus abdominal serositis.
- The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucas...
- Sensory Neuropathy With Sjögren's Syndrome, Thymoma, and Hypogammaglobulinemia.
- Autoantibodies to a 140-kd protein in juvenile Dermatomyositis are associated with calcinosis.
- Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
- Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/Dermatomyositis in UK Cauca...
- Treatment of myositis with "lower" dose corticosteroids.
- Clinical trials review: idiopathic inflammatory myopathy.
- Current approach to the treatment of polymyositis and Dermatomyositis.
- Dermatomyositis with erosive arthropathy: association with the anti-PL-7 antibody.
- Tacrolimus in refractory polymyositis with interstitial lung Disease.
- Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis.
- Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients.
- Classification criteria for the idiopathic inflammatory myopathies.
- Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes.
- Percutaneous needle muscle biopsy in the evaluation of patients with suspected inflammatory myopathy.
- Incidence of Systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.
- Cytokines and nitric oxide synthase inhibitor as mediators of adrenergic refractoriness in cardiac myocytes.
- NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes.
- Glucose and pyruvate regulate cytokine-induced nitric oxide production by cardiac myocytes.
- Inotropic, chronotropic, and radioligand binding characteristics of leukotriene B4 in cardiac myocyte, papillary muscle, and membrane preparations.
- Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity.
- Protein kinase A activation is required for IL-1-induced nitric oxide production by cardiac myocytes.
- Significance of anti-nuclear matrix antibodies in patients with in vivo speckled antinuclear antibody staining.
- New perspectives on osteoArthritis.
- cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes.
- Interleukin-6 (IL-6) as a mediator of stunned myocardium.
- Verapamil regulation of a defective SR release channel in the cardiomyopathic Syrian hamster.
- Therapy for myositis.
- Catalytic conversion of L-arginine to nitrate by platinum electrodes.
- Therapy of inflammatory myopathy.
- Classification and diagnostic criteria for polymyositis and Dermatomyositis.
- Positive inotropic effect of acetylcysteine in cardiomyopathic Syrian hamsters.
- Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes.
- Cytokine induction during cardiac surgery: analysis of TNF-alpha expression pre- and postcardiopulmonary bypass.
- A longitudinal study of functional disability in a national cohort of patients with polymyositis/Dermatomyositis.
- Adult respiratory distress Syndrome in polymyositis patients with the anti-Jo-1 antibody.
- Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
- Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes.
- A potential role for nitric oxide in myocardial stunning.
- Regulation of constitutive nitric oxide synthase activity by the human heart.
- Wegener's granulomatosis with delayed pulmonary and colonic involvement.
- Pasteurella multocida polyarticular septic Arthritis.
- Vasculitis in systemic sclerosis: association with Sjögren's Syndrome and the CREST Syndrome variant.
- Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-Dermatomyositis.
- Current management of polymyositis and Dermatomyositis.
- Incidence of polymyositis-Dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982.
- A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/Dermatomyositis.
- Negative inotropic effects of cytokines on the heart mediated by nitric oxide.
Schools
Pennsylvania State University College Of Medicine
Hershey Med Center Penn University
Hershey Med Center
University Of Pittsburgh
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
Conditions Treated
- Arthritis
- Bursitis
- Degenerative Disc Disease
- Dermatomyositis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Pittsburgh Magazine
- Fellow
- Fellow (FACR)
- Top MD
Education
-
University of Pittsburgh Medical Center -
Penn State University
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1356316004 | |
| NPPES Provider LastName | ODDIS | |
| NPPES Provider FirstName | CHESTER | |
| NPPES Provider ZIPCode | 152133403 | |
| NPPES Provider State | PA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 1327.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 111.0 | |
| Percent Opioid Claims | 8.36 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356316004 |
| Last Name Of The Provider | ODDIS |
| First Name Of The Provider | CHESTER |
| View All |
Similar Doctors
|
|
Dr. Joanne Sickeri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fotios Koumpouras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan Manzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robyn T. Domsic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest R. Vina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naveditha Mohan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip Balk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burton H. Pollock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy H. Kao, MD |
|
|
Dr. Pinky Vaidya, MD
This Doctor is OpenDoctor Recommended.
|